ChromaCon AG

Founded in 2008 and acquired by YMC in 2019, YMC ChromaCon at the TechnoPark in Zürich, Switzerland, serves as a hub for developing and commercializing continuous chromatographic process technologies. As part of the YMC Group, it holds a range of process and process control patents. Collaborating with YMC America, the company offers chromatography solutions from laboratory to GMP process scales, aiming to enhance bioprocessing efficiency. Their flagship product, the Contichrom CUBE, is a twin-column FPLC development system for continuous purification of peptides, oligonucleotides, mAbs, and small molecules. This system allows for multiple process capabilities and can directly scale up to the Contichrom TWIN systems, offering a 30-50% reduction in CAPEX and OPEX compared to traditional batch manufacturing. YMC ChromaCon focuses on providing advanced chromatography equipment to aid in the development and manufacture of next-generation chemical and biological medicines using continuous manufacturing technology.